The anticalcitonin gene-related peptide-receptor monoclonal antibody erenumab is effective and safe for treatment of rosacea-associated erythema and flushing, according to a study published in JAMA Dermatology.
Apr 17, 2024
0
0
Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy surgery. In contrast to previous practice, where ...
Mar 11, 2024
0
9
Prof. Dr. Grit Hein's latest assessments of empathic abilities once again challenge the old adage, "You can't teach an old dog new tricks." It seems that not only children but also adults can adopt empathic responses from ...
Feb 22, 2024
0
42
A team of neuroscientists and psychologists from the Perelman School of Medicine and the Indian Institute of Technology has found evidence suggesting that early hunter–gatherer groups may have benefited from the behavior ...
Community engagement is important for developing research involving patients with mental illness, and funding agencies are increasingly requiring such engagement. However, many researchers are unable to pursue advisory boards ...
Jan 25, 2024
0
0
A new case report titled "Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report" has been published in Oncotarget.
Jan 24, 2024
0
0
Daylight Saving Time (DST) might be influencing our internet habits, according to research from the University of Surrey and the University of Padova (Italy).
Jan 9, 2024
0
0
Work based policies must be designed to target barriers that night shift workers face when managing weight and metabolic health conditions, a Monash University-led review has found.
Nov 30, 2023
0
0
In Ontario, Canada, most COVID-19 vaccinations were administered by public health organizations and pharmacies rather than by family physicians. Researchers devised a practice facilitation intervention program to help family ...
Nov 27, 2023
0
0
A multi-million-pound landmark "vaccine damage" case is set to take place in London's High Court. The test case is being pursued by Jamie Scott who suffered a severe brain injury in April 2021 after receiving the Oxford-AstraZeneca ...
Nov 15, 2023
0
2
